Lewis D K, Peters Rph, Schijffelen M J, Joaki Grf, Walsh A L, Kublin J G, Kumwenda J, Kampondeni S, Molyneux M E, Zijlstra E E
Department of Medicine, University of Malawi College of Medicine, Blantyre.
Department of Microbiology, University of Malawi College of Medicine, Blantyre.
Malawi Med J. 2003 Jun;15(2):56-60. doi: 10.4314/mmj.v15i2.10778.
The aims of the study were to measure the prevalence and outcome of mycobacteraemia in febrile hospitalised adults; to determine what proportion could be identified using routine methods; to assess clinical indicators of mycobacteraemia and the usefulness of a diagnostic trial of anti-TB treatment. We prospectively examined adults with fever or a history of fever admitted to adult medical wards of QECH, Blantyre. All had blood cultured for bacteria and mycobacteria, chest x-ray and sputum smears. M. tuberculosis was the commonest blood isolate, affecting 57 of 344 patients (17%). In 44 (77%) patients with mycobacteraemia, TB was identified using routine investigations; in only 6 (11%) it was not suspected. Strong clinical indicators of mycobacteraemia were anaemia, HIV seropositivity, cough, chronic fever, and a clinical diagnosis of AIDS on the day of admission. Of nine patients selected for a therapeutic trial of TB treatment, six had mycobacteraemia, of whom five died during the trial. Mortality on short course chemotherapy on the TB ward after one month, was similar whether patients had mycobacteramia (21%) or not (32%). TB can be identified with routine methods in most patients with mycobacteraemia. If treated, mycobacteraemia has as good an early outcome as TB without mycobacteraemia. Strengthening of basic facilities is likely to improve detection and treatment of mycobacterial disease.
本研究的目的是测量发热住院成人中分枝杆菌血症的患病率和转归;确定使用常规方法能够识别的比例;评估分枝杆菌血症的临床指标以及抗结核治疗诊断性试验的效用。我们对入住布兰太尔伊丽莎白女王中央医院成人内科病房的发热或有发热史的成人进行了前瞻性研究。所有患者均进行了细菌和分枝杆菌血培养、胸部X光检查及痰涂片检查。结核分枝杆菌是最常见的血培养分离菌,344例患者中有57例(17%)感染。在44例(77%)分枝杆菌血症患者中,通过常规检查确诊为结核病;仅6例(11%)未被怀疑。分枝杆菌血症的有力临床指标为贫血、HIV血清学阳性、咳嗽、长期发热以及入院当天的AIDS临床诊断。在入选接受抗结核治疗试验性治疗 的9例患者中,6例有分枝杆菌血症,其中5例在试验期间死亡。在结核病病房接受短程化疗1个月后的死亡率,无论患者有无分枝杆菌血症(分别为21%和32%)均相似。大多数分枝杆菌血症患者可通过常规方法确诊结核病。如果进行治疗,分枝杆菌血症的早期转归与无分枝杆菌血症的结核病一样好。加强基础设施建设可能会改善分枝杆菌病的检测和治疗。